Dorsiflex

Dorsiflex is a topical medication that contains the non‑steroidal anti‑inflammatory drug etofenamate as its active ingredient. It is supplied as a cutaneous preparation, with the specific strength and dosage form not publicly disclosed, and is marketed within the European Union. The product is intended for external use to address pain and inflammation associated with musculoskeletal conditions, and it works by inhibiting cyclooxygenase enzymes to reduce prostaglandin production.

Dorsiflex is indicated for the topical management of several painful or inflammatory musculoskeletal conditions. - Relief of mild to moderate muscle aches and strains. - Treatment of joint pain related to osteoarthritis or rheumatoid arthritis. - Management of tendonitis and bursitis symptoms. - Support for sports‑related injuries such as sprains or contusions. - Adjunct therapy for postoperative or trauma‑induced inflammation when systemic NSAIDs are not preferred. - Application for localized back pain or neck stiffness where oral NSAIDs may cause gastrointestinal concerns. - Use in chronic inflammatory conditions such as ankylosing spondylitis when topical therapy is appropriate.

Topical etofenamate may cause skin‑related and systemic effects; the frequency and severity vary among individuals. These effects are generally reversible after discontinuation, but any unexpected reaction should be reported to a healthcare professional. Common: - Local skin irritation or erythema at the application site. - Pruritus or mild itching. - Dryness or peeling of the treated skin. - Sensation of warmth or burning. - Mild swelling or edema at the site. - Temporary discoloration or hyperpigmentation. Serious: - Allergic contact dermatitis with vesicles or swelling. - Severe skin ulceration or necrosis. - Systemic hypersensitivity reactions such as urticaria. - Signs of systemic NSAID toxicity (e.g., gastrointestinal bleeding, renal impairment). - Stevens‑Johnson syndrome or toxic epidermal necrolysis (very rare).

When using Dorsiflex, certain precautions help minimize risks and ensure appropriate use. - Avoid applying to broken, infected, or severely inflamed skin. - Do not use under occlusive dressings unless directed by a clinician. - Limit the amount and frequency according to product labeling to reduce systemic absorption. - Keep the product away from eyes, mucous membranes, and open wounds. - Discontinue use and seek medical advice if a rash or severe irritation develops. - Pregnant or breastfeeding individuals should consult a healthcare provider before use. - Patients with known NSAID hypersensitivity should avoid topical etofenamate.

Topical etofenamate can interact with other medications or substances; awareness of these interactions supports safe therapy. Avoid: - Concurrent use of systemic NSAIDs or COX‑2 inhibitors, which may increase overall prostaglandin inhibition. - Application together with other topical analgesics containing NSAIDs, to prevent additive local effects. - Avoid simultaneous use with topical products containing alcohol or solvents that may increase skin irritation. Use with caution: - Anticoagulants or antiplatelet agents, as systemic absorption could modestly affect bleeding risk. - Corticosteroid creams applied to the same area, which may alter skin integrity. - Herbal or over‑the‑counter products that sensitize the skin, such as menthol or capsaicin preparations. - Patients on diuretics should monitor renal function, because systemic NSAID absorption could affect kidney handling.